Table of Contents Author Guidelines Submit a Manuscript
Analytical Cellular Pathology
Volume 2015, Article ID 746856, 7 pages
http://dx.doi.org/10.1155/2015/746856
Research Article

PTEN Sequence Analysis in Endometrial Hyperplasia and Endometrial Carcinoma in Slovak Women

1Institute of Medical Biology, Genetics and Clinical Genetics, Faculty of Medicine and University Hospital Bratislava, Comenius University in Bratislava, Sasinkova 4, 81108 Bratislava, Slovakia
2Department of Biochemistry and Microbiology, Faculty of Food and Biochemical Technology, University of Chemistry and Technology, Prague, Technicka 5, 16628 Prague, Czech Republic
3Institute of Pathological Anatomy, Faculty of Medicine and University Hospital Bratislava, Comenius University in Bratislava, Bratislava, Sasinkova 4, 81108 Bratislava, Slovakia
4MEDIREX GROUP ACADEMY n.o., Galvaniho 17/C, 82016 Bratislava, Slovakia
5Clinical Pathology Presov, Ltd., Holleho 14, 08001 Presov, Slovakia
6Department of Clinical Genetics, St. Elizabeth Cancer Institute, Heydukova 10, 812 50 Bratislava, Slovakia

Received 1 April 2015; Accepted 13 May 2015

Academic Editor: Monica Cantile

Copyright © 2015 H. Gbelcová et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Jemal, R. Siegel, J. Xu, and E. Ward, “Cancer statistics, 2010,” CA Cancer Journal for Clinicians, vol. 60, no. 5, pp. 277–300, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. C. S. Diba, I. Pleško, and P. Hlava, Eds., Incidence of Malignant Cancer in Slovak Republic 2007, National Cancer Registry of Slovak Republic, National Health Information Center, Bratislava, Slovakia, 2012.
  3. J. V. Bokhman, “Two pathogenetic types of endometrial carcinoma,” Gynecologic Oncology, vol. 15, no. 1, pp. 10–17, 1983. View at Publisher · View at Google Scholar · View at Scopus
  4. G. L. Mutter, M.-C. Lin, J. T. Fitzgerald et al., “Altered PTEN expression as a diagnostic marker for the earliest endometrial precancers,” Journal of the National Cancer Institute, vol. 92, no. 11, pp. 924–931, 2000. View at Publisher · View at Google Scholar · View at Scopus
  5. J. Li, C. Yen, D. Liaw et al., “PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer,” Science, vol. 275, no. 5308, pp. 1943–1947, 1997. View at Publisher · View at Google Scholar · View at Scopus
  6. P. A. Steck, M. A. Pershouse, S. A. Jasser et al., “Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers,” Nature Genetics, vol. 15, no. 4, pp. 356–362, 1997. View at Publisher · View at Google Scholar · View at Scopus
  7. J.-O. Lee, H. Yang, M.-M. Georgescu et al., “Crystal structure of the PTEN tumor suppressor: implications for its phosphoinositide phosphatase activity and membrane association,” Cell, vol. 99, no. 3, pp. 323–334, 1999. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Tamura, J. Gu, T. Takino, and K. M. Yamada, “Tumor suppressor PTEN inhibition of cell invasion, migration, and growth: differential involvement of focal adhesion kinase and p130(Cas),” Cancer Research, vol. 59, no. 2, pp. 442–449, 1999. View at Google Scholar · View at Scopus
  9. A. Di Cristofano and P. P. Pandolfi, “The multiple roles of PTEN in tumor suppression,” Cell, vol. 100, no. 4, pp. 387–390, 2000. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Govatati, V. L. Kodati, M. Deenadayal, B. Chakravarty, S. Shivaji, and M. Bhanoori, “Mutations in the PTEN tumor gene and risk of endometriosis: a case-control study,” Human Reproduction, vol. 29, no. 2, pp. 324–336, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. S. G. Silverberg, R. J. Kurman, F. Nogales, G. L. Mutter, R. A. Kubik-Huch, and F. A. Tavassoli, “Epithelial tumors and related lesions,” in WHO Classification of Tumours, Pathology and Genetics, Tumours of the Breast and Female Genital Organs. Tumours of the Uterine Corpus, F. A. Tavassoli and P. Devilee, Eds., pp. 221–232, IARC Press, Lyon, France, 2003. View at Google Scholar
  12. J. I. Risinger, A. K. Hayes, A. Berchuck, and J. C. Barrett, “PTEN/MMAC1 mutations in endometrial cancers,” Cancer Research, vol. 57, no. 21, pp. 4736–4738, 1997. View at Google Scholar · View at Scopus
  13. J. I. Risinger, K. Hayes, G. L. Maxwell et al., “PTEN mutation in endometrial cancers is associated with favorable clinical and pathologic characteristics,” Clinical Cancer Research, vol. 4, no. 12, pp. 3005–3010, 1998. View at Google Scholar · View at Scopus
  14. S. B. Simpkins, S. Peiffer-Schneider, D. G. Mutch, D. Gersell, and P. J. Goodfellow, “PTEN mutations in endometrial cancers with 10q LOH: additional evidence for the involvement of multiple tumor suppressors,” Gynecologic Oncology, vol. 71, no. 3, pp. 391–395, 1998. View at Publisher · View at Google Scholar · View at Scopus
  15. G. L. Maxwell, J. I. Risinger, C. Gumbs et al., “Mutation of the PTEN tumor suppressor gene in endometrial hyperplasias,” Cancer Research, vol. 58, no. 12, pp. 2500–2503, 1998. View at Google Scholar · View at Scopus
  16. W. M. Lin, E. Forgacs, D. P. Warshal et al., “Loss of heterozygosity and mutational analysis of the PTEN/MMAC1 gene in synchronous endometrial and ovarian carcinomas,” Clinical Cancer Research, vol. 4, no. 11, pp. 2577–2583, 1998. View at Google Scholar · View at Scopus
  17. D. Kong, A. Suzuki, T. T. Zou et al., “PTEN1 is frequently mutated in primary endometrial carcinomas,” Nature Genetics, vol. 17, no. 2, pp. 143–144, 1997. View at Publisher · View at Google Scholar · View at Scopus
  18. H. Tashiro, M. S. Blazes, R. Wu et al., “Mutations in PTEN are frequent in endometrial carcinoma but rare in other common gynecological malignancies,” Cancer Research, vol. 57, no. 18, pp. 3935–3940, 1997. View at Google Scholar · View at Scopus
  19. B. Konopka, A. Janiec-Jankowska, D. Czapczak et al., “Molecular genetic defects in endometrial carcinomas: microsatellite instability, PTEN and beta-catenin (CTNNB1) genes mutations,” Journal of Cancer Research and Clinical Oncology, vol. 133, no. 6, pp. 361–371, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. K. Kurose, K. Bando, K. Fukino, Y. Sugisaki, T. Araki, and M. Emi, “Somatic mutations of the PTEN/MMAC1 gene in fifteen Japanese endometrial cancers: evidence for inactivation of both alleles,” Japanese Journal of Cancer Research, vol. 89, no. 8, pp. 842–848, 1998. View at Publisher · View at Google Scholar · View at Scopus
  21. H. Sun, T. Enomoto, M. Fujita et al., “Mutational analysis of the PTEN gene in endometrial carcinoma and hyperplasia,” The American Journal of Clinical Pathology, vol. 115, no. 1, pp. 32–38, 2001. View at Publisher · View at Google Scholar · View at Scopus
  22. B. Konopka, A. Janiec-Jankowska, Z. Paszko, and M. Goluda, “The coexistence of ERBB2, INT2, and CMYC oncogene amplifications and PTEN gene mutations in endometrial carcinoma,” Journal of Cancer Research and Clinical Oncology, vol. 130, no. 2, pp. 114–121, 2004. View at Publisher · View at Google Scholar · View at Scopus
  23. B. Konopka, Z. Paszko, A. Janiec-Jankowska, and M. Goluda, “Assessment of the quality and frequency of mutations occurrence in PTEN gene in endometrial carcinomas and hyperplasias,” Cancer Letters, vol. 178, no. 1, pp. 43–51, 2002. View at Publisher · View at Google Scholar · View at Scopus
  24. 2015, http://stats.oecd.org/index.aspx?DataSetCode=HEALTH_STAT#.
  25. 2015, http://faostat3.fao.org/compare/E.
  26. H. Arem, M. J. Gunter, A. J. Cross, A. R. Hollenbeck, and R. Sinha, “A prospective investigation of fish, meat and cooking-related carcinogens with endometrial cancer incidence,” British Journal of Cancer, vol. 109, no. 3, pp. 756–760, 2013. View at Publisher · View at Google Scholar · View at Scopus